CRHR1 rs1876828: Understanding Stress Response and Medication
The rs1876828 variant is a single-nucleotide polymorphism located within the CRHR1 gene, which plays a critical role in the body's stress response system. Research has investigated its potential association with how individuals respond to certain medications, particularly inhaled corticosteroids used for asthma.
What each genotype means
Common stress response profile
This is the most frequently observed genotype for this variant in many populations. Research into the CRHR1 gene suggests that variations in this region may influence how the body's stress system, specifically the HPA axis, regulates cortisol release during psychosocial stress. Because the evidence linking this specific variant to stress outcomes is currently limited, this genotype is considered a standard or baseline profile.
This is the major homozygous genotype, carried by the majority of individuals in most global populations.
Heterozygous stress response profile
Carrying one copy of the minor allele (A) means your genetic profile for this CRHR1 variant is mixed. While some CRHR1 variants have been associated with differences in cortisol response during stress tests, the evidence for this specific marker remains limited and inconsistent across studies. There is no clinical consensus on how this genotype influences your individual stress physiology.
This genotype is found in a significant portion of the population, consistent with the reported minor allele frequency of approximately 25–35%.
Minor allele stress profile
You carry two copies of the minor allele (A) for this CRHR1 variant. While research has explored how CRHR1 polymorphisms may modulate cortisol release during acute stress, the evidence for this specific variant is limited and does not provide a clear or definitive impact on your health. This finding should be viewed as a research-based observation rather than a clinical indicator.
This is the least common genotype, occurring in roughly 6–12% of individuals depending on ancestral background.
What is rs1876828 and Where is it Located?
The variant rs1876828 is a specific genetic change, or single-nucleotide polymorphism (SNP), found within the CRHR1 gene. This gene is responsible for encoding the corticotropin-releasing hormone receptor 1, a protein that acts as a key mediator in the endocrine, behavioral, and immune responses to stress. Located on human chromosome 17, the CRHR1 gene spans approximately 20 kilobases of genomic DNA and contains multiple exons. The rs1876828 SNP represents a variation at a single position in the DNA sequence, where individuals may carry different nucleotides. Because this variant sits within a gene that regulates the hypothalamic-pituitary-adrenal (HPA) axis—the body's primary stress-management system—scientists have long been interested in whether this specific location influences how people physiologically react to environmental stressors or pharmacological interventions that target these pathways.
The Role of the CRHR1 Gene
The CRHR1 gene provides instructions for creating the corticotropin-releasing hormone receptor 1. This receptor is primarily found in the pituitary gland and various regions of the brain. When the body encounters stress, the hypothalamus releases corticotropin-releasing hormone (CRH), which binds to the CRHR1 receptor. This binding event triggers a cascade of signals that ultimately leads to the release of cortisol, the body's primary stress hormone. By modulating this receptor's activity, the body can fine-tune its response to acute and chronic stressors. Because of its central role in HPA axis regulation, the CRHR1 gene is a frequent subject of study in fields ranging from psychiatry to respiratory medicine. Variations in this gene, such as rs1876828, are hypothesized to potentially alter the sensitivity or expression of these receptors, thereby influencing how an individual's body manages stress-induced hormone production.
Research Associations and Evidence Strength
The evidence linking rs1876828 to specific clinical outcomes is currently considered limited and mixed. Some studies have suggested that this variant may be associated with variations in lung function improvement following inhaled corticosteroid therapy in patients with asthma. For instance, certain research has observed that individuals carrying specific alleles might show a more pronounced increase in forced expiratory volume (FEV1) after treatment compared to others. However, these findings have not been consistently replicated across all clinical datasets, and some studies have failed to reach statistical significance after correcting for multiple testing. Furthermore, while the gene itself is implicated in the regulation of neurotransmitters and glucocorticoid responses in various conditions—including depression and chronic obstructive pulmonary disease—the specific impact of the rs1876828 variant remains a subject of ongoing investigation. It is important to view these associations as statistical observations rather than definitive clinical predictors.
Population Frequency
The rs1876828 variant is found across diverse global populations, with the minor allele (A) typically showing a frequency ranging from approximately 0.25 to 0.35. This means that a significant portion of the population carries at least one copy of the minor allele, making it a relatively common genetic variation. Because the frequency can vary based on ancestral background, researchers often account for population structure when conducting association studies to ensure that findings are not skewed by demographic differences. While these frequency statistics provide a baseline for understanding how common the variant is, they do not indicate the functional impact of the variant in any specific individual. Genetic diversity is a hallmark of human populations, and the prevalence of this SNP highlights the natural variation present in genes governing our stress response systems.
What You Can and Cannot Do With This Information
Understanding your genetic profile regarding rs1876828 can be an interesting way to learn about the biological pathways involved in stress and medication response. However, it is crucial to recognize that this information is not a diagnostic tool. The associations observed in research studies are statistical in nature and do not account for the complex interplay of other genes, environmental factors, and lifestyle choices that influence health. You cannot use this information to predict your personal response to any medication or to diagnose a health condition. If you are concerned about how you respond to asthma medications or other treatments, you must discuss these topics with your clinician or pharmacist. They are the only ones qualified to interpret your medical history and provide guidance on dosing or treatment adjustments based on established clinical guidelines.
How common is this variant?
The minor allele (A) of rs1876828 has a frequency of approximately 0.25–0.35 in global populations, making it a common genetic variant.
Frequently asked questions
Does the rs1876828 variant mean I have a stress disorder?
No. This variant is simply a common genetic difference in the CRHR1 gene. It does not diagnose any stress-related disorder or indicate that you have a medical condition.
Can I use this SNP to change my asthma medication?
No. You should never change your medication based on genetic information. Always consult your doctor or pharmacist before making any changes to your prescribed treatment plan.
Is the evidence for rs1876828 strong?
The evidence is currently considered limited. While some studies have shown associations with medication response, these results have been mixed and are not sufficient for clinical decision-making.
Where can I find more information about CRHR1?
You can explore resources like MedlinePlus Genetics or the NCBI Gene database for general information about the function of the CRHR1 gene in the human body.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1876828?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRHR1
HPA-axis modulating variant in CRHR1 that interacts with psychosocial stress exposure to affect emotional reactivity and stress-coping traits.
Key intronic polymorphism in the corticotropin-releasing hormone receptor 1 gene that moderates endocrine and emotional vulnerability after exposure to early life trauma.
Variant in the corticotropin-releasing hormone receptor 1 gene that moderates hypothalamic-pituitary-adrenal axis reactivity and vulnerability to stress-induced mood disturbances.
Intronic CRHR1 variant associated with neuroendocrine stress sensitivity.
Tag variant in the CRHR1 locus associated with HPA axis regulation.
Variant in the corticotropin-releasing hormone receptor 1 gene associated with HPA-axis reactivity.